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Summary
One of the six predicted Proteus mirabilis autotrans-
porters (ATs), ORF c2341, is predicted to contain a
serine protease motif and was earlier identified as an
immunogenic outer membrane protein in P. mirabilis.
The 3.2 kb gene encodes a 117 kDa protein with a
58-amino-acid-long signal peptide, a 75-kDa-long
N-terminal passenger domain and a 30-kDa-long
C-terminal translocator. Affinity-purified 110 kDa AT
exhibited chymotrypsin-like activity and hydrolysed
N-Suc–Ala–Ala–Pro–Phe–pNa and N-Suc–Ala–Ala–
Pro–Leu–pNa with a KM of 22 mM and 31 mM, respec-
tively, under optimal pH of 8.5–9.0 in a Ca2+-dependent
manner. Activity was inhibited by subtilase-specific
inhibitors leupeptin and chymostatin. Both the cell-
associated and purified form elicited cytopathic
effects on cultured kidney and bladder epithelial cells.
Substrate hydrolysis as well as cytotoxicity was
associated with the passenger domain and was com-
promised upon mutation of any of the catalytic resi-
dues (Ser366, His147 and Asp533). At alkaline pH
and optimal cell density, the AT also promoted auto-
aggregation of P. mirabilis and this function was
independent of its protease activity. Cytotoxicity,
autoaggregation and virulence were significantly
reduced in an isogenic pta mutant of P. mirabilis.
Proteus toxic agglutinin (Pta) represents a novel
autotransported cytotoxin with no bacterial homo-
logues that works optimally in the alkalinized urinary
tract, a characteristic of urease-mediated urea
hydrolysis during P. mirabilis infection.
Introduction
Protein secretion in Gram-negative bacteria facilitates
nutrient acquisition, initiates interactions with the eukary-
otic host and mediates bacterial cell–cell communication.
For pathogenic bacteria, protein secretion by type II, III
and IV systems is often required for full virulence. These
protein secretion systems may export toxic proteins
across the outer membrane (OM) or inject them directly
into the host cell (Stathopoulos et al., 2000; Cianciotto,
2005; Mota and Cornelis, 2005; Backert and Meyer,
2006). In the last two decades, a new family of virulence
proteins that are unique to Gram-negative bacterial patho-
gens, known as autotransporters (ATs), was discovered.
These proteins are exported to the outside of the cell by
the type V or the AT secretion pathway. ATs are modular
proteins with three domains: a long leader peptide
required for Sec-dependent transport across the inner
membrane, an N-terminal passenger or alpha domain
that determines the virulence function of the AT, and a
C-terminal hydrophobic translocator or beta domain that
facilitates the translocation of the alpha domain across the
OM into the extracellular milieu (Henderson et al., 1998).
This basic structural organization of ATs is highly con-
served, but their functions vary widely; this diversity is
typically attributed to the activity of the surface-expressed
alpha or passenger moiety. The passenger domain may
mediate host invasion, autoagglutination or haemaggluti-
nation, confer resistance against host serum proteins and
antibodies, or act as a secreted cytotoxin (Henderson and
Nataro, 2001). Due to their surface localization or release
from the bacterium, ATs directly interact with the host and
hence have been instrumental in elucidating previously
unknown molecular events during host–pathogen
interactions. In two examples, purified ATs Hap from
Haemophilus influenzae (Liu et al., 2004) and BrkA from
Bordetella pertussis (Cainelli Gebara et al., 2007) were
used as vaccines against these pathogens and more
ATs are being pursued as potential surface-expressed
antigens (Wells et al., 2007).
Proteus mirabilis, a Gram-negative dimorphic
human uropathogen differentiates between a vegetative
swimmer and a hyper-flagellated swarmer cell. P. mirabilis
causes complicated urinary tract infections (UTIs) among
individuals with anatomical abnormalities of the urinary
tract or in patients with long-term indwelling catheters and
may cause bacteraemia among the elderly (Mobley,
1996a), making it one of the most common nosocomial
infections.
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The genome sequence of the catheter-associated
P. mirabilis strain HI4320 reveals 3685 open reading
frames in a 4.3 Mb single circular chromosome along with
a stable 36 kb plasmid (Pearson et al., 2008). Six putative
ATs are annotated: three (Orfs c0844, 2126 and c2341) as
proteases and three (Orfs 2122, 2174 and 2575) as puta-
tive adhesins or haemagglutinin-like ATs (Pearson et al.,
2008). Putative AT c2341 has been recognized in our
laboratory as a surface-expressed antigenic protein when
stained with antisera from mice chronically infected with
P. mirabilis, suggesting a role for this protein in vivo (G.R.
Nielubowicz and H.L.T. Mobley, unpubl. data). It is anno-
tated as an AT with a subtilisin-like serine protease motif.
Subtilisins are pre-protein convertases that are known to
catalyse key functions in the cell such as protein activation
as a post-translational modification, and cellular trafficking
making them significant therapeutic targets in both eukary-
otic and prokaryotic systems (Hutton, 1990). Together
these features identify c2341 as a candidate virulence
factor of P. mirabilis.
In this study we characterized the structure and function
of c2341 and, using a mouse model of ascending UTI,
established its significance in the pathogenesis of P. mira-
bilis UTIs. The protein was purified to homogeneity, and the
biochemical characteristics of the putative protease were
determined using synthetic substrates and enzyme inhibi-
tors. The nature of its interaction with human bladder and
kidney epithelial cell lines was elucidated using in vitro cell
culture studies. Unique characteristics of this AT indicate
that it functions both as a bacterial cell–cell agglutinin
and as an OM-associated cytotoxic protease with an
alkaline pH optimum. Therefore, we designated this novel
autotransported cytotoxin Pta, for Proteus toxic agglutinin.
Results
Structure of Pta
The pta gene (c2341) of P. mirabilis strain HI4320 is anno-
tated as an AT with a subtilisin-like protease motif. The
3183-bp-long gene encodes a hypothetical 1072-amino-
acid-long protein with a theoretical molecular size of
117 kDa. Using BLAST analysis, no proteins shared signifi-
cant amino acid sequence identity with the putative
passenger domain of Pta. The closest homologues, dis-
playing only ~20% amino acid sequence identity, were the
thermostable enzyme Fervidolysin (Fls) from Fervidobac-
terium pennivorans (Kluskens et al., 2002), Serine
protease A (PspA), a protease-like putative AT from
Pseudomonas chlororaphis (Swiss-Prot/Tr-EMBL), and
SubA subunit of SubAB toxin from Shiga-Toxin produc-
ing Escherichia coli (Paton et al., 2004). Amino acid
sequence identity within the alpha domain was restricted
to regions spanning the identified catalytic residues of
these proteases (Fig. 1B). Using the N-terminus sequenc-
ing, the signal sequence was identified to be 40 amino
acids long with the potential cleavage site between resi-
dues A40 and Y41. The amino acid sequence of c234l
analysed using MOTIF search found that the amino acids
1–730 form the passenger or the alpha domain of the
putative AT. The protein belongs to the family of serine
proteases with Ser366, His147 and Asp533 forming the
putative serine catalytic triad of the protease (Fig. 1A and
B). No RGD motifs or lipid attachment motifs were
detected in the passenger domain suggesting that the
protein does not bind to any known receptors on the
eukaryotic host.
C-terminal residues 731–1072 were predicted to con-
stitute the beta domain of the AT. The C-terminus shows
similarity with various OM proteins and beta domains of
ATs from Pseudomonas spp. (data not shown). Analysis of
the probable membrane topology of this protein revealed
that hydrophobic amino acids account for more than 50%
of this domain with at least nine different stretches of
hydrophobic residues with intermittent hydrophilic resi-
dues, which together form the antiparallel beta sheets
and the connecting loops of the OM beta barrel of the
translocator (Fig. 1A). The sequence terminated in the
YIFQYNS motif, which partially conforms to the typical AT
Fig. 1. Pta domains, active site and purification.
A. Schematic representation of the structure of Pta. The 1072-amino-acid-long autotransporter protein (upper construct) with a signal
sequence (grey shade), N-terminal passenger domain (spotted) and the C-terminal translocator domain (white) with the positions of
antiparallel beta sheets (black bars) shown. The protein is annotated as a subtilisin-like alkaline serine protease. The amino acids Ser366,
His146 and Asp533 that form the putative catalytic serine protease triad are indicated in the passenger domain. Schematic representation of
the expression constructs is shown (lower construct). In each case Pta was cloned into pET21A to express it as a C-terminal 6X-His tag
fusion protein.
B. Alignment of the active site of Pta and its homologues. Alignment of putative catalytic domains of Pta with the sequence of Ser, His and
Asp. Pta, Proteus toxic agglutinin of P. mirabilis; SubA, Toxic subunit of AB5 type toxin SubAB of STEC; Fls, Fervidolysin of Fervidobacterium
pennivorans; and PspA, Serine protease A of Pseudomonas chlororaphis. The numbers above the Pta fragments indicate the residue number
of the terminal amino acids in Pta. Alternative consensus residues at a given position are shown vertically. The known active-site residues in
each subtilase catalytic domain are shown in bold type. The asterisk indicates Pta residues that do not match the consensus sequence.
C. Expression and purification of Pta and Pta(S366A). Whole-cell or outer membrane protein (6 mg) of E. coli BL21plysS expressing vector control
(CTL), Pta or Pta(S366A) (Pta*) was separated on a 10% SDS-PAGE. The two arrows (at 100 kDa marker) indicate the larger pre-protein and the
smaller mature Pta protein. The arrow at ~30 kDa indicates OmpA used as a marker for enriched OM protein fraction. U = uninduced culture;
I = E. coli BL21plysS induced with 1 mM IPTG; and M = molecular size marker. The next to last lane represents the affinity-purified ~110 kDa
mature form of Pta to ~95% homogeneity. Mobility of protein standards is shown in kDa.
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motif (Y/V/I/F/W)-X-(F/Y/W). Interestingly, Pta is cysteine-
deficient, in accordance with an observation that known
AT proteins contain no or few cysteine (Henderson et al.,
2004).
Expression and purification of Pta and Pta-a
Pta wild type, active-site serine mutant Ser366Ala
denoted as Pta* or the Ser366Ala and His147Ala double
mutant were overexpressed as recombinant proteins in
E. coli BL21plysS. Pta was purified as a ~110 kDa protein
in either case from the OM of the bacterium (Fig. 1C). Two
important features of Pta were observed from the above
results; first, Pta exists as two forms, a larger ~120 kDa
protein and a shorter protein of ~110 kDa, and the latter
species is the major form. Interestingly, the S366A or
S366A/H147A active-site mutants showed a similar effi-
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ciency in processing, implying no role for Ser366 in this
process. We confirmed the identity of both proteins as Pta
by mass spectrometric analysis. In addition, N-terminal
sequencing of the ~110 kDa protein band was determined
to be EKGQVFDVDG, which aligns well with the amino
acid sequence of Pta between residues Glu127 and
Gly136. This confirms that the 120 kDa protease under-
goes a secondary processing between residues Y126 and
E127 to yield a catalytically mature 110 kDa form, a feature
commonly seen in eukaryotic subtilisin-like proteases
(Steiner, 1998). The OM fraction of the Pta-expressing
E. coli BL21plysS also shows a protein with a molecular
weight of ~20 kDa (Fig. 1C). The protein band was iden-
tified by mass spectrometry as a cleaved product of an
unrelated protein PhoA, an alkaline phosphatase precur-
sor in E. coli.
Second, the mature Pta is stably expressed as a
110 kDa protein in the OM suggesting that the passenger
domain of Pta is not cleaved away from the translocator
as seen in most protease-like ATs; rather it remains intact
in the OM (Fig. 1C). We confirmed this observation by
comparing the protein profiles of culture supernatants
from E. coli BL21 expressing the pET21A vector control,
or that expressing each of the Pta variants, but found no
indication of alpha/passenger domain processing at the
OM (data not shown). As this phenomenon (of intact alpha
and beta domains) is seen with ATs that are adhesins,
haemagglutinins or agglutinins, we hypothesized a similar
role for Pta in P. mirabilis.
Significance of the beta domain in OM
localization of Pta
Autotransporter proteins that mediate the functions of
cell–cell agglutination or adhesion to the host (as hypoth-
esized for Pta) show varied lengths of the beta domain.
ATs with as short as 60- to 100-amino-acid-long beta
domains are seen in case of YadA (Yersinia entero-
colitica), Hia and Hsf (H. influenzae) or NadA (Neisseria
meningitidis) that assume trimeric forms for the successful
translocation of the passenger domains across the OM
and form a functional adhesive pocket on the surface of
the pathogen (Cotter et al., 2005; 2006). To determine
whether the entire translocator domain of the Pta is
required for the translocation of Pta-a across the OM, we
made eight different truncations in the beta domain of Pta
at positions corresponding to the predicted hydrophilic
helices that bridge two adjacent hydrophobic beta sheets
in the translocator. We also generated multiple point
mutations (Y1063A, F1065A and Y1067A) towards the
C-terminus of the beta domain to determine the signifi-
cance of the hydrophobic residues in the translocation of
Pta into the OM of the cell. Figure 2A shows the sche-
matic of four of these truncations (T-844, T-910, T-1016
and T-1054) and the altered Pta (designated as 1072*).
Each of these versions was individually expressed in
E. coli BL21plysS, and protein localization was deter-
mined by immunostaining with Anti-Pta antiserum
(Fig. 2B). All truncated versions were stably expressed in
Fig. 2. Role of beta domain in Pta
localization.
A. Schematic representation of amino acid
positions at which truncations (T) were made
in the beta domain of Pta (top). Pta-1072*
with amino acid residues Tyr1063, Phe1065
and Tyr1067 altered to respective Ala is
shown (bottom).
B. Each of the truncated or altered versions
was expressed in E. coli BL21plysS and 6 mg
each of the soluble (S) or the outer
membrane (O) protein fractions was
electrophoresed on a 10% SDS-PAGE. E. coli
BL21plysS carrying pET21A as control (CTL).
Proteins were immunoblotted with Anti-Pta
antiserum (1:750) and Goat Anti-Rabbit
IgG-HRP conjugate (1:20000). Arrows identify
the truncated Pta.
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E. coli BL21 and were detected in the soluble fraction, but
not in the OM fraction of the cell (Fig. 2B). This suggested
that the entire beta domain is required for the OM trans-
location of the protein, and that the truncated versions of
the beta domain do not adopt an oligomeric form to
perform this function. Furthermore, the inability of even
the shortest truncation at amino acid residue 1054
(T-1054) or the mutated 1072* version to successfully
transport the passenger domain to the OM reiterates the
significance of the hydrophobic residues in the C-terminus
of the AT in forming an anchor to the OM.
Interaction of Pta-expressing E. coli BL21 with human
bladder epithelium in vitro
Pta appears as a stable 110 kDa protein in both its
OM-associated and in its purified form. This led to the
hypothesis that Pta may act either as an agglutinin or as
an adhesin as seen in case of Hia, TibA, YadA, and other
similar ATs where the alpha domain is not cleaved from
the beta domain in the OM (Klemm et al., 2006; Girard
and Mourez, 2006). To determine a possible role for Pta in
the virulence of P. mirabilis, we adopted a gain-of-function
approach and infected human bladder epithelial cells
independently with E. coli BL21 expressing vector alone,
wild-type Pta, the serine protease mutant Pta(S366A) or the
alpha domain (Pta-a). We observed cell–cell aggregation
of E. coli-Pta cells as shown in Fig. 3B (solid arrow).
Aggregation was also seen among E. coli-Pta(S366A) cells
(Fig. 3C, solid arrow), suggesting no role for protease
activity in this process. This phenotype, however, was not
observed with either E. coli BL21 expressing the vector
control or Pta-a, confirming that the phenotype is Pta
dependent and that its OM localization is essential. Also,
we observed no increase in adhesion of E. coli BL21-Pta
cells to the bladder epithelial cells (when compared with
vector control), and repeated attempts to quantify the
E. coli-Pta recovered from the infected monolayer were
unsuccessful, suggesting Pta does not mediate adhesion
of the bacterium to the host cell. Indeed, in many cases
the recovery of E. coli-Pta was many folds lower than that
of E. coli-Pta(S366A) or E. coli-pET21A (data not shown).
Surprisingly, in addition to the autoaggregation pheno-
type, infection of tissue culture with E. coli BL21-Pta
resulted in the condensation of the bladder cell cytoplasm,
detachment from the surface and cell lysis (Fig. 3B,
dotted arrow), suggesting a toxin-like activity associated
with Pta. This phenotype was specific to wild-type Pta and
was not observed with E. coli BL21 vector control
(Fig. 3A) or either of the Pta variants (active-site mutant or
passenger domain alone) (Fig. 3C and D). We observed a
very rare incidence of vacuole formation (in less than 5%
of cells) in the host cell cytoplasm when infected with
E. coli-Pta(S366A), but this was not consistently observed
when the infections were repeated with either whole cell
or the purified Pta(S366A). Quantification of lactate dehydro-
Fig. 3. Interaction of E. coli BL21plysS with
human bladder epithelial cell monolayer.
UMUC-3 cells were cultured as a monolayer
on poly L-lysine-treated coverslips and were
infected with E. coli BL21plysS expressing
pET21A vector alone as control; Pta
(E. coli-Pta); Pta(S366A) (E. coli-Pta*); or Pta-a
(E. coli-Pta-a). Giemsa-stained cells were
imaged at 100¥ magnification. Solid arrows
indicate bacterial cells and dashed arrows
point to the lysed host cells. Bar = 100 mM.
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genase release (as a measure of bladder cell lysis) when
infected with each of the E. coli strains was also per-
formed using incubation with Triton X-100 and E. coli
expressing vector only as controls. E. coli expressing Pta
lysed 70% of bladder epithelial cells, whereas E. coli
expressing Pta* and E. coli expressing Pta-a resulted in
lysis of only 18.3% and 11% cells, respectively, above the
background (data not shown). The data further confirmed
the interpretations made from microscopic analysis.
In these initial observations Pta demonstrated a combi-
nation of two distinct phenotypes that has not been
reported in any AT studied so far: Pta promoted cell–cell
aggregation of the bacterium and, when in interaction with
the host, elicited a cytopathic effect. Both of these fea-
tures have strong implications for the pathogenesis of
P. mirabilis infection as this bacterium is known to form
efficient biofilms on catheters that aids in the long-term
persistence of the infection in the host (Stickler et al.,
1993).
Time- and dose-dependent lysis of bladder cells by Pta
Cytopathic effects of ATs such as Sat (Guyer et al., 2002),
Pet (Navarro-Garcia et al., 2007) and EspC (Navarro-
Garcia et al., 2004) is shown to be associated with their
protease activities. To estimate the cytotoxic effects of Pta
quantitatively, we determined the time-course of Pta-
mediated bladder cell lysis. Bladder epithelial cells were
incubated with increasing concentrations (0–8 mg ml-1)
of Pta, or each of its active-site mutants (Pta(S366A) or
Pta(S366A/H147A)) and release of soluble LDH into the culture
supernatant was used as an index of cell lysis. Figure 4A
illustrates the extent of host cell lysis using various con-
centrations of Pta, with maximum lysis measured upon
incubation with 8 mg ml-1 (7.2 nM) for 120 min. In agree-
ment with the predicted catalytic role of Ser366 and
His147, the ability of the active-site serine mutants
Pta(S366A) and Pta(S366A/H147A) to lyse the host cells was
reduced to about 20% of that of the wild-type Pta (Fig. 4A)
in the same time period tested. Indeed, incubating bladder
cells with 15 nM of each of the mutant proteins for longer
incubation period (up to 16 h) did not result in any signifi-
cant increase in the overall lysis of the bladder cells (data
not shown).
To determine the mode of host cell damage induced by
Pta, cells treated either with buffer control or with Pta
(8 mg ml-1 or 7.2 nM) were microscopically examined at
various time intervals. Cytotoxicity was first observed at
30 min after toxin addition (Fig. 4B; bottom row); alter-
ation of the host cell morphology due to membrane
damage was followed by leakage and condensation of the
cell cytoplasm at 60 min, and breakdown of the cell com-
ponents, resulting in lysis and detachment from the
surface ensured after 90–120 min of incubation (Fig. 4B;
bottom row). This phenotype was not observed in cells
incubated with phosphate-buffered saline (PBS) for the
same time intervals (Fig. 4B, top row).
Expression and purification of the passenger domain
We cloned the putative passenger domain (residues
1–730) of Pta and affinity purified a ~75 kDa Pta-a-6X-His
to > 95% homogeneity from the soluble fraction of E. coli
BL21 (Fig. 5A and B) and the protein identity was con-
firmed by mass spectrometry. Pta-a also appeared as
both pre- and catalytically mature protease with the latter
being the predominant form (Fig. 5B). The two active-site
mutants of Pta-a, Pta-a(S366A) and Pta-a(H147A) were also
purified by similar procedure and the pre-, as well as
mature subtilase was observed in each case when
stained with Anti-Pta antisera (Fig. 5C). N-terminal
sequence of the mature ~75 kDa protein determined in
each case aligned with that of the mature ~110 kDa Pta
suggesting a similar secondary processing event. Com-
parison of the OM protein profiles of E. coli expressing
vector alone (as control) with that expressing Pta-a both
by Commassie stained gel (Fig. 5B) and by immunoblot
analysis (Fig. 5C) showed no indication of Pta-a in the
OM of the cell. This confirms our earlier prediction that
the C-terminal amino acid residues 730–1072 of Pta form
the translocator domain and are essential for the transport
of Pta across the OM.
Protease activity of the putative subtilase, Pta
The presence of conserved catalytic residues in Pta and
other subtilase-like enzymes such as SubA, Fls and PspA
suggested that Pta may possess a protease-like activity
associated with the alpha domain of the AT. Consequently,
we probed the substrate specificity and optimum condi-
tions for protease activity of purified Pta-a (passenger
domain) towards various synthetic p-nitroanilide sub-
strates (see Experimental procedures). Pta-a hydrolysed
only chymotrypsin-specific substrates as indicated by
the hydrolysis of p-nitroanilides with phenylalanine and
leucine residues at the P1 position (Fig. 6A) with much
greater affinity, but did not catalyse the hydrolysis of sub-
strates with arginine, valine or alanine at that position to
any appreciable extent (Fig. 6A). The protease activity
was greatly diminished either by changing the Ser366
(P < 0.01) or His147 (P < 0.05) to alanines or by treating
the protease either with PMSF (phenyl-methylsulphonyl
fluoride) (Fig. 6A and B and Table 1) or with DFP (diiso-
propyl flourophosphate) (Table 1), suggesting the signifi-
cance of Ser366 and His147 in catalysis. However,
inhibition of protease activity was greater in S366A point
mutation than that observed in H147A mutant. The rates
of the reaction of Pta-a for substrate S1 were approxi-
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mately 35 and 25 times higher than that the S366A and
H147A variants respectively. An analysis of the enzyme
and substrate kinetics showed that Pta cleaves N-Suc–
Ala–Ala–Pro–Phe–pNa with a KM = 22 mM (Fig. 6C) and
N-Suc–Ala–Ala–Pro–Leu–pNA with a KM = 31 mM (data
not shown). However, specific substrates for other serine
proteases, such as BApNa (trypsin), N-Suc–Ala–Ala–
Ala–pNa (Fig. 6A) and N-Suc–Ala–Ala–Pro–Val–pNa
(data not shown), were not cleaved by P. mirabilis Pta-a.
A range of synthetic as well as naturally occurring inhibi-
tors was used to determine the nature of the active site of
Pta-a. Protease activity was inhibited ~90% by treating
either with PMSF or with DFP, indicating the role of Ser
and His residues as the catalytic residues (Fig. 6A). In
accordance with our prediction, inhibitors of cysteine-
proteases did not affect its activity (Table 1); these results
taken together classify Pta as a serine protease. Some
inhibitors are instrumental in determining the inhibitor P1
positions, and also help in determining the enzyme
specificity. We employed the microbial-derived inhibitors
leupeptin and chymostatin that are specific to serine and
thiol proteases and found complete inhibition of the pro-
tease activity (Table 1). In addition, inhibitors such as STI
(soybean trypsin inhibitor) and BBI (Bowman-Birk trypsin
inhibitor) that are specific against subtilisin-like enzymes
showed up to 60–70% inhibition, whereas the trypsin-
specific inhibitors TLCK (N-alpha-p-Tosyl-L-lysine-
chloromethyl ketone hydrochloride) and TPCK (N-alpha-
p-Tosyl-L-phyenylalanine chloromethyl ketone) had only
moderate or no effect respectively (Table 1). Together the
Fig. 4. Interaction of purified Pta with bladder epithelial cell monolayer.
A. Time- and dose-dependent lysis of UMUC-3. UMUC-3 cells were cultured to 80% confluence in tissue culture-treated 96-well plate and
infected independently with known concentrations of Pta, Pta* or Pta(S366A/H147A). Extent of lysis by Pta is represented as a per cent of maximum
bladder cell lysis by Triton X-100 treatment. Data are mean  SE obtained from three independent studies each performed in triplicate.
**P < 0.01. Pta-8, Pta 8 mg ml-1; Pta-6, Pta 6 mg ml-1; Pta-4, Pta 8 mg ml-1; and Pta-2, Pta 2 mg ml-1; Pta(S366A)-8, 8 mg ml-1 Pta (Ser366Ala)
active-site mutant; and Pta(S366A/H147A)-8, 8 mg ml-1 Pta (Ser366Ala/His147Ala) active-site double mutant.
B. Qualitative estimation of cytotoxicity. UMUC-3 cells were treated either with PBS + 0.05% zwittergen (top) or with 8 mg ml-1 Pta (bottom) and
images were taken after staining with Giemsa. Bladder cells treated with Pta for 120 min were not subjected to extensive washes to prevent
complete loss of lysed cells from the glass surface. Arrows point to lysed bladder cells. Images are taken at 60¥ magnification. Bar = 100 mm.
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substrate specificity and the inhibitor profile confirm Pta
as a subtilisin-like serine protease.
Cytoplasmic urease activity of Proteus and the accumu-
lation of bicarbonate as well as ammonium ions results in
an alkaline micro-environment surrounding P. mirabilis in
the human urinary tract (Mobley and Warren, 1987). As
Pta is a surface-expressed protease, we hypothesized
that pH may play a significant role in the function of this
protease. To determine the pH-dependent stability as well
as the optimum pH for Pta activity, we pre-incubated
Pta-a in carbonate buffer in a range of pH 5–11 spanning
acidic, neutral and alkaline conditions and then tested its
activity against its specific substrate N-Suc–Ala–Ala–Pro–
Phe–pNa. Pta demonstrated maximum substrate hydroly-
sis between pH 8.5 and 9.0 and the activity was reduced
by at least 40% either under neutral (pH 7.0) or under
higher alkaline conditions of pH 9.5 and 10 (the latter case
might result in the precipitation of the protein due to the
presence of Ca2+-binding pocket). However, a significant
loss of protease activity was observed in the acidic range
(pH 5–6) (Fig. 6B), although the protein was resistant to
acidic degradation as seen using gel electrophoresis
(data not shown). We hence classified Pta as a subtilisin-
like alkaline protease.
Cytotoxicity is associated with the passenger domain
As for other characterized ATs, the passenger or alpha
domain (Pta-a) of Pta contains all catalytic residues
required for substrate hydrolysis. To test the hypothesis
that the alpha domain is sufficient for cytotoxicity, we
tested the activity of Pta-a and each of its active-site
mutants over a range of kidney and bladder cell lines. As
expected, incubation with purified Pta-a (8 mg ml-1 or
9.2 nM for 120 min) resulted in complete lysis of human
kidney (HEK293), bladder cells (UMUC-3) and Vero
monkey kidney cells as indicated by the measured LDH
release (Fig. 7A). In accordance with the enzymatic activ-
ity, cytotoxicity of the active-site mutants (S366A and
H147A) and PMSF-treated Pta-a was significantly (P <
0.01) reduced (Fig. 7A). However, both hamster kidney
(BHK21) and mouse kidney (MMK-5) cell lines showed
moderate resistance against Pta-a activity (Fig. 7A).
These results confirmed that the alpha domain of Pta is
Fig. 5. Structure of Pta-a and purification.
A. Schematic of various constructs of Pta-a. The 730-amino-acid-long alpha or passenger domain of Pta; Pta-a, active-site mutants Pta-a(S366A)
or Pta-a(H147A) were each cloned into pET21A and overexpressed as a C-terminus 6X-His-tagged fusion protein in E. coli BL21plysS.
B. Purification of Pta-a. Pta-a was overexpressed in E. coli BL21plysS. Pre- and mature forms of ~75 kDa Pta-a in the soluble protein fraction
or in their purified form are identified by arrows. Protein fraction from E. coli BL21plysS expressing the vector alone serves as the control
(CTL). The last two lanes show the OM protein fraction; the possible position of Pta-a is shown by the asterisk.
C. Immunoblot of Pta-a and OM fractions. Purified active-site variants of the passenger domain Pta-a (S366A) and Pta-a (H147A), 6 mg of
OM protein each from E. coli expressing pET21A (CTL) and E. coli expressing Pta-a (Pta-a) were run on a 10% SDS-PAGE, transferred onto
a nitrocellulose membrane and stained using polyclonal Anti-Pta antisera (1:750) and Goat Anti-Rabbit IgG-HRP conjugate (1:10000).
Arrows at 75 kDa marker identify pre- and mature forms of Pta-a and the lower arrow at ~30 kDa indicates OmpA protein used as a marker
for OM (negatively stained). M = molecular size marker.
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the active protease and is responsible for the cytotoxicity
of Pta.
Pta-a induces actin depolymerization and destabilizes
nuclear membrane integrity
Vero cell lines were independently incubated with
PBS + 0.05% zwittergen, and either wild-type Pta-a, Pta-
a(S366A), or PMSF-treated Pta-a (Fig. 7B) for 60 min to
closely monitor the initial events in host cell damage. Cells
were subsequently stained with the FITC-phalloidin and
DAPI to visualize actin and nuclei respectively. Vero cells
incubated with wild-type Pta-a (Fig. 7B, the second panel)
showed membrane disruption leading to release of cyto-
plasmic contents indicated by the dispersion and
degradation of actin filaments (indicated by arrows). Con-
sequently, this also affected the nucleus as the DNA was
stained more lightly in Pta-a intoxicated cells than in the
cells treated with either of the protein variants or with
buffer control (Fig. 7B). Upon longer incubation (up to 2 h)
we observed complete loss of actin staining and the cyto-
plasm was condensed to the walls of the nuclei. The
nuclei too were stained very lightly and lost their structural
integrity (data not shown). Although, to our knowledge,
this is the first report of nuclear damage induced by a
cytotoxic AT, we predict that it is an indirect consequence
due to certain downstream cellular events in the host
rather than a direct effect of Pta.
Fig. 6. Protease activity of Pta.
A. Substrate specificity and active-site determination. Proteases (20 nM Pta-a, Pta-a(S366A), Pta-a(H147A) and Pta-a-PMSF inactivated) were
assayed against 100 mM of each substrate, S1: N-Suc–Ala–Ala–Pro–Phe–pNa; S2: N-Suc–Ala–Ala–Pro–Leu–pNa; S3: Benzoyl–Arg–pNa; and
S4: N-Suc–Ala–Ala–Ala–pNa in 50 mM NaPO4 buffer, pH 8.3, containing 20 mM CaCl2 and 0.005% Triton X-100. The protease activity of
Pta-a was significantly (**P < 0.01) higher than the protease activity of each of the point mutants or the PMSF-inactivated protease. One unit
of protease activity = nmol substrate hydrolysed per minute per milligram of protein.
B. The pH optimum for protease activity of Pta-a (20 nM) was determined using S1 (100 mM), in the assay buffer with a range of pH. One unit
of protease activity = nmol substrate hydrolysed per minute per milligram of protein.
C. KM for S1 was determined by using 20 nM Pta-a and a range of substrate concentrations (10–150 mM) at pH 8.5. v = nmol substrate
hydrolysed per minute.
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Induction and stability of Pta
Environmental factors such as temperature, osmolarity,
pH and metal ions have been shown to influence the
expression of various virulence factors. Even though evi-
dence of regulators controlling the expression of AT is
minimal (Tukel et al., 2007), external factors such as men-
tioned above were proven to regulate the expression of
ATs (Henderson et al., 1999). To determine the factors
that either induce the expression of or stabilize Pta at the
OM, P. mirabilis HI4320 was cultured in LB under various
conditions (see Experimental procedures) and protein
expression was detected by immunoblotting. Table 2 lists
the conditions and their effects on the expression of Pta in
P. mirabilis. Pta expression was twofold higher at 37°C
than at 25°C, a feature expected with virulence determi-
nants in pathogens. Pta was moderately repressed under
the conditions of iron starvation or high salt where the
cellular resources are mainly channelled towards upregu-
lation of iron receptors present in the OM. Interestingly,
expression of Pta was induced about two- and threefold
when the bacteria were cultured in alkaline conditions or
in medium supplemented with calcium ions, respectively,
but not in the presence of Mg2+ (Fig. 8; Table 2). Gene
expression at the transcript level was also determined
using quantitative reverse transcription polymerase chain
reaction (RT-PCR) assay (Fig. 8B). The pta gene was
upregulated at least three- to fourfold when cultured in
alkaline conditions of pH 9.0 or at 37°C (Fig. 8B) and
downregulated when the pathogen was grown under
acidic pH (5.0) or at lower temperatures (25°C) (Fig. 8B).
Addition of Fe2+ or Mg2+ ions resulted only in a moderate
to no increase in gene expression at either pH 7.0 or 9.0,
whereas addition of Ca2+ showed moderate increase only
at pH 7.0 but not at pH 9.0. We hence concluded that
unlike iron and magnesium, presence of calcium to alka-
line environment helps Pta maintain a stable conformation
in the OM. These results suggest that P. mirabilis adapts
to the conditions in its immediate environment in the liquid
culture and regulates or stabilizes its key OM virulence
factors to facilitate infection.
Inactivation and complementation of pta in
P. mirabilis HI4320
To assess the role of Pta in the virulence of P. mirabilis, we
constructed a pta-deficient (ptaWaphA3) strain of HI4320
using Targetron®. A kanamycin cassette was inserted
towards the 5′ end (encoding the N-terminal passenger
domain) of the gene resulting in the complete loss of
protein expression. Insertional inactivation of pta was con-
firmed both by PCR (data not shown) and by immunoblots
using polyclonal Anti-Pta antiserum (Fig. 9A). The mutant
was complemented in trans by either the wild-type pta
gene (resulting in full cytotoxicity) or the S366A active-site
variant (diminished cytotoxicity) expressed under the
control of an inducible promoter (see Experimental
procedures). Expression and OM localization of Pta in the
complemented strain was confirmed using immunoblots
(Fig. 9A); no trace of Pta was seen in the concentrated
supernatants (data not shown). Growth kinetics of the
mutant were very similar to that of the wild-type when
tested in LB, DMEM, M9 and urine, both at 37°C and at
25°C (data not shown), suggesting no role for Pta in
nutrient or ion transport across the OM.
Characterization of Pta in P. mirabilis HI4320
The first indication of Pta-mediated cell–cell aggregation
of E. coli BL21 was seen when the bladder cells were
infected with E. coli BL21 expressing Pta (Fig. 3). We
asked if a similar phenotype can be associated with Pta in
P. mirabilis.
Evidence of cytotoxicity. We tested the relative abilities of
P. mirabilis HI4320 (WT), the isogenic mutant ptaWaphA3,
WT overexpressing Pta (WT/pBAD-pta), or the mutant
overexpressing either the WT-Pta or its active-site serine
mutant S366A (see Experimental procedures) to lyse
bladder epithelial cells using LDH release as an index of
cytotoxicity. Infection with 107 colony-forming units (cfu)
of the strain overexpressing Pta resulted in complete lysis
of the host cells in 4 h compared with about 50% lysis by
107 cfu of WT HI4320 in the same time period correlating
this phenotype to the protease activity of Pta (P < 0.01)
(Fig. 9B). Cytotoxicity was attenuated using whole
washed cells of the isogenic pta mutant of HI4320 (P <
0.05), and was restored to the wild-type levels only when
provided with WT Pta but not with Pta(S366A) (P < 0.05). The
extent of bladder cell lysis was very similar (~25% of the













a. Pta was allowed to complex with an inhibitor (concentration
subject to the nature of the inhibitor). After pre-incubation for 30 min,
the residual protease activity was measure towards 100 mM N-Suc–
Ala–Ala–Pro–Phe–pNa.
b. Relative to Proteinase activity under optimum conditions of pH
(8.5), temperature (37°C), substrate and native enzyme concentra-
tions (100 mM and 50 nM respectively).
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Pta-induced lysis), however, when infected with the con-
centrated supernatants of each strain suggesting this is a
Pta-independent event (mediated by haemolysin or other
cytotoxic proteins in P. mirabilis), as well as confirming the
location of Pta to the OM of the pathogen. Similar extent
of host cell lysis in the supernatants together with basal
cytotoxicity exhibited by the mutant strain indicates the
presence of other secreted or OM-associated toxic pro-
teases in Proteus.
Evidence of autoaggregation. In a similar fashion, the
ability of all the above strains to autoaggregate was also
assessed. All strains were individually re-suspended in
phosphate buffer (pH 8.5) to a cell density of about 460–
480 Kletts and density was measured at different time
intervals. Wild-type strain HI4320 showed moderate auto-
aggregation with approximately 60% reduction in cell
density over 300 min incubation. As hypothesized, the
rate of autoaggregation was significantly increased in the
wild-type strain overexpressing Pta, with the bacterial cell
density decreasing significantly after the first 120 min and
with no significant decrease after about 240 min (Fig. 10).
Conversely, the rate of autoaggregation was significantly
reduced in ptaWaphA3 strain in the same time period.
However, this phenotype was restored in the mutant strain
overexpressing either the wild type or the active-site
serine mutant of Pta (Fig. 10). These results suggested
that under the optimum conditions of protein expression,
pH and cell density, P. mirabilis can autoaggregate and
that Pta is perhaps one of the key proteins that promote
Fig. 7. Cytotoxicity of Pta-a on cell lines.
A. Interaction of Pta-a with various host cell
lines. Confluent host cell lines were treated
with 8 mg ml-1 Pta-a, Pta-a(S366A) or Pta-a
(inactivated with PMSF) for 120 min and the
release of intracellular LDH by the host cells
was measured. Extent of host cell lysis by the
protein is represented as a per cent of
maximum lysis by Triton X-100 treatment,
normalized with values obtained from buffer
treatment alone. Mean  SE obtained from
three independent studies each performed in
triplicate is shown (**P < 0.01).
B. Immunofluorescent detection of host cell
damage. Confluent monolayer of Vero kidney
cell line was treated with of PBS + 0.05%
zwittergen; 8 mg ml-1 each of Pta-a; Pta-a
inactivated with PMSF; and Pta-a(S366A)
(Pta-a*). Representative images of cells
stained with FITC-phalloidin, DAPI and merge
are shown. Arrows indicate actin degeneration
in infected cells. Magnification = 100¥;
bar = 100 mm.
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this phenomenon. Interestingly, even though Ser366 is
essential for catalysing substrate hydrolysis and cyto-
toxicity, alteration of this residue did not influence the
process of autoaggregation. The data here confirm the
bi-functional nature of the AT Pta in P. mirabilis, demon-
strating a unique phenotype combination of bacterial cell–
cell aggregation and OM-associated cytotoxicity.
Role of Pta in the virulence of P. mirabilis. Pta was first
identified in our laboratory as one of the OM surface-
expressed proteins of P. mirabilis recognized by antisera
from mice chronically infected with Proteus (G.R. Nie-
lubowicz and H.L.T. Mobley, unpubl. data). This was a
preliminary indication that this protein was expressed
during infection of the host. We performed co-challenge
experiments where mice were infected with equal
numbers of parental strain HI4320 and its isogenic pta
mutant (2.5 ¥ 107 of each strain) and tested the relative
abilities of each strain to colonize the urinary tract and the
spleen of mice. The ptaWaphA3 strain was significantly
outcompeted by the parent strain in the bladder (P < 0.05)
and both the kidney and spleen (P < 0.01) (Fig. 11). In five
Table 2. Effect of selected conditions on the expression of Pta.
No. Condition of growtha
Fold change
in expressionb,c
1 Exponential phase of growth 2
2 25°C -3
3 42°C –
4 Acidic (pH 5.0) -3
5 Alkaline (pH 9.0) 2.5
6 0.5 M NaCl -2
7 20 mM CaCl2 3
8 MgCl2 (0.5, 1, 2 mM) –
9 Iron chelation (15 mM desferral) -2
10 Excess iron (0.5 mM FeSO4) –
a. P. mirabilis HI4320 cultured under different conditions or harvested at different growth phases.
b. OM protein was stained with Anti-Pta antibody to estimate the amount of protein expressed.
c. Relative to protein expressed in the culture grown at 37°C, pH 7.0, harvested at the late log early stationary phase of growth.
–, no change.
Fig. 8. Induction of Pta.
A. P. mirabilis HI4320 was cultured in LB
under different conditions and the outer
membrane fraction (6 mg) from each was
electrophoresed on a 10% SDS-PAGE.
Concentrations (in mM) for Mg2+ and Ca2+ are
given. Immunostaining was performed with
Anti-Pta antiserum (1:750) and Goat
Anti-Rabbit IgG-AP conjugate (1:10 000).
Density of each band was estimated using
ImageJ software. Arrow identifies Pta in each
lane. The upper minor band in Ca2+ lane is
the pre-protease form of Pta.
B. Quantitative PCR for P. mirabilis HI4320
pta. Fold change in pta expression when
cultured in various conditions of temperature,
pH and metal ion supplementation or iron
chelation is given. Data were normalized to
rpoA (DNA-dependent RNA polymerase
Alpha) expression levels, and changes were
determined by using LB medium (37°C,
pH 7.0) as the calibrator.
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Fig. 9. Role of Pta in P. mirabilis.
A. Detection of Pta in wild type, mutant and
complemented strain. OM fractions (6 mg)
from each strain were electrophoresed on a
10% SDS-PAGE and immnoblotted with
Anti-Pta antiserum (1:1500) and Goat
Anti-Rabbit IgG-HRP conjugate (1:20 000).
Arrow indicates immuno-stained Pta in each
case. The ~65 kDa non-specific band was
used as the loading control.
B. Infection of bladder cells with P. mirabilis.
P. mirabilis was cultured until mid-exponential
phase (OD600 = 0.6) in alkaline LB (pH 8.5)
supplemented with CaCl2 and 5% glycerol
and was induced for 3 h with 5% arabinose
(where appropriate). Confluent bladder
epithelial cells were infected with different cell
counts of P. mirabilis for 4 h. Extent of bladder
cell lysis by whole cells of P. mirabilis is
represented as a per cent of maximum cell
lysis by Triton X-100 treatment. Data are
represented as mean  SE of three
independent experiments, each conducted in
triplicate. Significant differences (in bladder
cell lysis) when compared with the treatment
with 107 wild-type bacteria are indicated by
*P < 0.05; **P < 0.01. WT: P. mirabilis parent
strain; WT/pBAD-pta: P. mirabilis HI4320
strain overexpressing pta; pta: ptaWaphA3;
pta/pBAD-pta: pta expressing wild-type pta on
pBAD; pta/pBAD-pta(S366A): pta expressing
the active-site S366A mutant of pta on pBAD.
Fig. 10. Pta-dependent autoaggregation of P. mirabilis. Bacteria were cultured and induced (when appropriate) in a similar fashion. Bacteria
were then re-suspended to a cell density of approximately 460–480 Klett units in phosphate buffer (pH 8.5) supplemented with CaCl2. Data
represent mean decrease in density of cell suspension (due to simultaneous increase in clumping and precipitation to the bottom of the tube)
from three independent experiments. Difference in the Klett units at the end of 300 min incubation is significant between wild type and each of
WT/pBAD-pta (P < 0.01), pta/pBAD-pta (P < 0.01), pta/pBAD-pta(S366A) (P < 0.01) and pta (P < 0.05). WT: P. mirabilis parent strain;
WT/pBAD: WT expressing pBAD vector alone as control; WT/pBAD-pta: P. mirabilis HI4320 strain overexpressing pta; pta: ptaWaphA3;
pta/pBAD: ptaWaphA3 expressing pBAD vector alone as control; pta/pBAD-pta: pta expressing wild-type pta on pBAD; pta/pBAD-pta(S366A):
pta expressing the active-site S366A mutant of pta on pBAD.
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of the 15 mice infected (with 1:1 ratio of wild type and pta
strain of) P. mirabilis, the numbers of mutant bacteria were
below the level of detection, strongly suggesting the
mutant to be attenuated. Urine samples collected from
five of the 15 mice in this study were contaminated and
hence excluded from the data analysis. Of the remaining
10 mice tested for bacteria in urine, we found no signifi-
cant difference between the wild-type and the mutant
bacteria recovered from these samples (P = 0.13)
(Fig. 11). This is the only cytotoxic AT protein affecting the
colonization of a pathogen in its host, apart from the VacA
in Helicobacter pylori (Salama et al., 2001), inactivation of
which compromises the ability of the mutant to colonize
the host.
Discussion
Pta is an inducible subtilisin-like alkaline protease AT. Orf
c2341 is annotated as a putative AT with a subtilisin motif
(Pearson et al., 2008). Subtilases are pre-protein conver-
tases which, in eukaryotic cells, play a pivotal role in the
processing of most precursor proteins in the secretory
pathway (Steiner, 1998). In eukaryotes, these enzymes
are themselves synthesized as pre-proteins and later
undergo processing near their N-terminus, transforming
them into catalytically active proteases (Seizen, 1996).
However, such a phenomenon is rare in prokaryotes.
Here we observe that P. mirabilis Pta exhibits a process
similar to that seen in eukaryotes, with a longer pre-
protein form (120 kDa) and an abundant shorter mature
protease (110 kDa) (Fig. 1C). Even though a similar
pattern was observed when overexpressed in P. mirabilis
(data not shown), the abundance of the pre-protein form
was much lower than that seen in E. coli BL21, suggest-
ing an efficient processing of Pta in the native Proteus
strain. Also this indicates that the shorter form is the
catalytic protein. We expressed the full-length AT (Pta)
and the passenger domain (Pta-a) in E. coli BL21 and
affinity purified both proteins to > 95% homogeneity
(Figs 1C and 5B). With the use of a broad range of sub-
strates, inhibitors and assay conditions, we classified Pta
as a protease belonging to the family of subtilisin-like
alkaline serine proteases (Fig. 6 and Table 1). Active-site
substitutions confirmed that an indispensable Ser366 and
moderately critical His147 together with Asp533 form the
catalytic triad of this protease, suggesting that other His or
Asp residues that are in close proximity to the catalytic
pocket may interact with Ser366 to transfer electrons
during substrate cleavage; a feature usually found in
subtilisin-like serine proteases (Seizen, 1996). This pro-
tease activity resides in the passenger domain and is also
responsible for the cytotoxic activity of the protease. Resi-
dues 730–1072 form an approximately 30 kDa transloca-
tor domain which is essential in its native form for the OM
localization of the AT (Fig. 5B).
The hallmark of a Proteus UTI is the formation of kidney
and bladder stones, as well as catheter obstruction due to
stone encrustation (Warren et al., 1982; 1987; Mobley
and Warren, 1987, Johnson et al., 1993; Mobley, 1996b).
Stone formation is due to the activity of the cytoplasmic
urease that hydrolyses urea in the urine to CO2 and
ammonia; accumulation of the latter causes an increase
in the pH and subsequent precipitation of magnesium
ammonium phosphate (struvite) and calcium phosphate
(apatite) crystals around the bacterium. Indeed, this alka-
linized urinary tract would require that extracellular and
surface-expressed bacterial proteins and enzymes have
peak activity at the elevated pH that is maintained
throughout a P. mirabilis infection. Here we demonstrate
that temperature (37°C), pH (8.5–9.5), growth phase
(exponential) and Ca2+ concentration (20 mM) are optimal
for Pta expression in P. mirabilis (Fig. 8 and Table 2).
These conditions simulate the environment that
P. mirabilis encounters, and indeed creates, during infec-
tion of the urinary tract.
Pta is a bi-functional AT with both cytotoxin and auto-
agglutinin activities. The subtilisin-like protease SubA of
the AB5 type toxin from STEC was the most recently
discovered cytotoxic subtilisin identified in non-Bacillus
species (Paton et al., 2004). SubA internalizes into the
eukaryotic host cell and inactivates a major chaperone
BiP resulting in host cell lysis (Paton et al., 2006). Here we
Fig. 11. Co-challenges of CBA/J mice with P. mirabilis HI4320 and
the isogenic pta mutant. The assessment of virulence of
ptaWaphA3 in a CBA/J mouse model of ascending UTI, 7 days
after co-challenge, with the parent strain. Each symbol represents
log10 cfu per millilitre of urine or cfu per gram of tissue from an
individual mouse. The solid symbols represent the wild-type counts
and open symbols represent the counts of the pta mutant. The
dotted line indicates the limit of detection. Solid black bars
represent the median log10 cfu per millilitre of urine or cfu per gram
of tissue, respectively, from a total of 15 mice for bladder, kidney
and spleen and 10 for urine. Two-tailed P-values were determined
by Wilcoxon matched pairs signed ranks.
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demonstrate the interaction of Pta (both in its cell-
associated and in its purified form) leads to lysis of the
cultured bladder epithelial cells (Figs 3, 4 and 7). There-
fore Pta is the newest member of the group of cytotoxic
ATs found in enteric pathogens. The mode of action of
Pta, however, differs greatly from other known cytotoxic
ATs such as Pet, Sat or VacA. Intoxication is mediated
neither by formation of vacuoles in the host cytoplasm as
induced by Sat (Guyer et al., 2002) and VacA (Harris
et al., 1996), nor by the direct disruption of the cytoskel-
eton as seen in case of EspC or Pet (Navarro-Garcia
et al., 1999; 2004). Repeated attempts to detect Pta in the
host cell cytoplasm using fluorescent microscopy were
unsuccessful, suggesting either that the mechanism of
Pta action was external or that the amount of Pta inter-
nalized in the susceptible host cell is below the limit of
detection. We hypothesize that Pta first punctures the
host cell membrane leading to the leakage of cytosol. The
loss of cell cytoplasm and the resulting osmotic stress
perhaps then triggers the depolymerization of actin
filaments (Fig. 7B). This may indirectly destabilize the
nuclear membrane resulting in the loss of its structural
integrity. The mode of action of Pta illustrates diverse
ways in which ATs can intoxicate the host cell.
Autoaggregation is one of the prominent functions
mediated by ATs and has been demonstrated for
AIDA-1, Ag43, Cah and TibA (Klemm et al., 2006). Few
of these agglutinins, however, exhibit dual or multiple
functions such as the invasion of or adhesion to the host
or to its extracellular matrix (Girard and Mourez, 2006).
Here we demonstrate that Pta exhibits the bi-functional
phenomenon by mediating the autoaggregation of bac-
terial cells and elicits cell damage when in contact with
the host (Figs 3, 8B and C). That Pta mediates auto-
aggregation was clearly demonstrated in P. mirabilis
HI4320 and was independent of its proteolytic activity
catalysed by Ser366 (Fig. 10). It is, however, interesting
to note that even though overexpression of Pta acceler-
ated the rate of autoaggregation of P. mirabilis, the
process was not completely inhibited in the isogenic pta
mutant (Fig. 10). During the preparation of this manu-
script, Rocha et al. published a report suggesting a role
for mrpA (encodes the major pilin of MR/P fimbria) in the
autoaggregation of P. mirabilis (Rocha et al., 2007). In
their studies MrpA contributed to the autoaggregation of
the pathogen, but inactivation of the gene did not com-
pletely abolish the phenotype. We propose that both
MR/P fimbria and Pta play a role in autoaggregation in
P. mirabilis, but their expression in the host may be spa-
tially or temporally regulated. We have also identified
that pH is a critical factor in the induction of Pta (Fig. 8,
and Table 2), hence, P. mirabilis may co-ordinate the
expression of Pta under circumstances that are different
from that of MrpA.
Autotransporters with bi- or tri-functional phenotypes,
such as adhesion, invasion and autoaggregation, are not
uncommon; however, the combination of autoaggrega-
tion and cytotoxic functions makes Pta unique. ATs that
elicit cytopathic effects (e.g. Pet, Sat or VacA) on the
host are shown to release their passenger domain into
the extracellular milieu. In the case of Pta, the passen-
ger domain remains intact with its translocator domain in
the OM but still functions as a cytotoxic protease. ATs
that mediate cell–cell aggregation, haemagglutination or
adhesion to the host cell have not been shown to elicit
cytopathic effects on the host as seen with Pta. Thus
P. mirabilis Pta illustrates the diverse mechanisms by
which ATs can augment the virulence of Gram-negative
pathogens.
Pta is a newly recognized virulence factor in P. mirabilis.
Proteus infections can be more serious than their E. coli
counterparts as they are often complicated by renal stone
formation, and are not always responsive to antibiotic
therapy (Mobley, 1996a). A repertoire of established viru-
lence factors contributes to these complicated ascending
UTIs. A few of these are strongly immunogenic (Li and
Mobley, 2002, Coker et al., 2000) including flagellin (FlaA),
fimbrial adhesin (MrpH) and the urease (UreA) (Li et al.,
2002). The genome sequence of strain HI4320 predicts six
putative ATs in this uropathogen. As for the case of Uro-
pathogenic E. coli (UPEC) strain CFT073, the six ATs in
P. mirabilis can be classified as protease-like, adhesin-like
or haemagglutinin-like ATs based on their putative function
(Pearson et al., 2008). In the absence of an effective type
III secretion system in P. mirabilis (Pearson and Mobley,
2007), it is expected that ATs play a major role
in the virulence of this uropathogen. Of these, we
have reported the structure–function relationship of the
subtilisin-like protease AT encoded by Orf c2341 and,
based on its observed phenotype in vitro, we named it Pta,
for Proteus toxic agglutinin. The functions associated with
Pta were also shown to be of significant importance in the
persistence of the pathogen in the host (Fig. 11).
Cytopathic effects caused by P. mirabilis in infected
individuals have been an issue of critical clinical
importance. Elegant studies in the early 1990s signifi-
cantly contributed into identifying the roles of haemolysin
(HpmA) and urease in the cytotoxic effects of P. mirabilis
in vitro using cultured epithelial cells (Swihart and Welch,
1990; Mobley et al., 1991; Chippendale et al., 1994).
Even though the phenotype was shown to be hpmA
dependent in vitro, there was no significant difference in
the histology of bladder and kidney of mice infected with
either the wild type or the isogenic hpmA mutant (Swihart
and Welch, 1990). Based on these results the authors
predicted a role for other unknown virulence factors that
contributed to the observed cytotoxicity of the hpmA
mutant in the host (Swihart and Welch, 1990).
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We suggest that in earlier in vivo studies by Swihart
et al. (Swihart and Welch, 1990), AT Pta together with
other uncharacterized protease-like ATs may have con-
tributed to the background cytotoxicity in mice infected
with the hpmA strain. In this study we have demonstrated
that growth in alkaline and calcium-rich medium condi-
tions that mimic the host during Proteus infection is
required for expression and activity of Pta. These condi-
tions were instrumental in identifying the role of Pta in the
cytotoxicity exhibited by P. mirabilis. However, further
studies to compare the histopathology of mice infected
with wild-type or the pta hpmA double mutant will be
helpful in determining the precise role of Pta in the patho-
genesis of P. mirabilis infections.
In conclusion, we identified a novel bi-functional AT
protein, Pta, as an important virulence factor in the uro-
pathogen P. mirabilis. This study not only opens a new
area for further research in the field of Proteus but also
provides a wide scope for research in the rapidly growing
field of AT proteins. ATs have also been tested for use
as antigens in subunit or multivalent vaccines against
Gram-negative pathogens (Wells et al., 2007). Hence,
further investigation into the antigenic properties of Pta
may make it a valuable resource in our ongoing efforts to
design a multivalent vaccine against Proteus.
Experimental procedures
Bacterial strains and plasmids
Bacterial strains and plasmids used in this study are listed in
Table 3. Uropathogenic P. mirabilis catheter-associated strain
HI4320 was used as parent wild-type strain. E. coli Top10
was used for DNA manipulations. Plasmid pET21A that
contains IPTG-inducible T7 promoter was used for over-
expressing the protein in E. coli BL21plysS.
Media and reagents
Luria–Bertani broth (LB broth) or agar contained 5 g l-1 and
0.5 g l-1 NaCl for E. coli and P. mirabilis respectively. Media
were supplemented with ampicillin (100 mg ml-1), kanamycin
(25 mg ml-1), chloramphenicol (20 mg ml-1) and tetracycline
(15 mg ml-1) as appropriate. Leupeptin, chymostatin, STI,
BBI, TLCK, TPCK, DFP, PMSF, the p-nitroanilide (-pNa)
substrates N-Suc–Ala–Ala–Pro–Phe–pNa, N-Suc–Ala–Ala–
Pro–Leu–pNa, benzoyl–Arg–pNa (BApNa), N-Suc–Ala–Ala–
Pro–Val–pNa, N-Suc–Ala–Ala–Ala–pNa were all purchased
from Sigma-Aldrich Chemical Company (St Louis, MO).
In silico analyses
The putative amino acid sequence of PMI2341 was analysed
by BLAST (http://www.ncbi.nih.gov./blast) to determine its
sequence identity and similarity with other known proteins.
Sequence alignments and analyses were performed using the
bioinformatic program suite available at (http://usexpasy.org).
Signal peptide was predicted using SignalP (http://www.
cbs.dtu.dk/services/SignalP). Identification of amino acid resi-
dues that form the putative catalytic site of the protease and
that form the beta domain of the AT was performed using
MOTIF search (http://motif.genome.jp/). The topology of the
beta domain (OM spanning hydrophobic residues and the
connecting hydrophilic loops) in the C-terminus of the protein
was predicted using PredictProtein (http://www.predictprotein.
org/).
Cloning and overexpression of Pta E. coli BL21plysS
The 3.2 kb gene pta (PMI2341) was amplified by PCR from
the genomic DNA of HI4320 using primers PTA-For and PTA-
Rev (lacking the stop codon) carrying BamHI and XhoI sites,
respectively, at their 5′ ends. The PCR product was cloned
into the compatible restriction sites in the expression vector
pET21A to generate plasmid to facilitate the expression of a
C-terminal 6X-His-tagged fusion protein.
Table 3. Primers used in this study.
Name 5′-3′ sequence Restriction site
PTA-For AGGTACAGAGGATCCATGAACAAAGAAATA BamHI
PTA-Rev ATAAGGTCTCGAGTTAGAAATTAATTTTCAATAT XhoI
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Strategene’s Quick Change® Site Directed Mutagenesis
kit was used to create point mutations at nucleotides corre-
sponding to residue Ser366 and construct an active-site
serine mutant of Pta in plasmid pSAP2010. Primers
(PtaS366AFor and PtaS366ARev) were designed as directed
by the manufacturer, and plasmid pSAP2000B was used as
the template DNA. To generate a S366A and H147A, primers
(HIS147AFor and HIS147ARev) were used to generate
His147 to Ala147 point mutation in pSAP2010 (which carries
S366A mutation). The resulting plasmid was designated
pSAP2041 (Table 4). Point mutations were confirmed by
sequencing the resulting plasmids at the University of
Michigan DNA Sequencing Core facility.
To overexpress Pta (or its active-site Ser mutant), plasmid
pSAP2000B or pSAP2010 were individually transformed
into the overexpression strain E. coli BL21plysS. E. coli
BL21plysS transformed with pET21A alone was used as
vector control. Overnight culture of E. coli BL21plysS carrying
the pta clone or the vector control was inoculated to a 1:100
dilution into fresh LB broth supplemented with ampicillin
(100 mg ml-1) and chloramphenicol (20 mg ml-1) and cultured
at 37°C with constant shaking to an OD600 of 0.6. IPTG was
added to the culture to a final concentration of 1 mM and the
expression was induced for 3 h. Protein expression was con-
firmed by running whole-cell extracts of E. coli expressing
pta, pta(S366A) or the vector control on 10% SDS-PAGE fol-
lowed by staining with Commassie Brilliant Blue.
Purification of C-terminus 6X-His-tagged Pta,
Pta(S366A) or Pta(S366A/H147A)
Escherichia coli BL21plysS carrying the clone of interest was
harvested after a 3 h induction with IPTG. Bacteria were
lysed using French Pressure Cell (20 000 psi) and the lysate
was centrifuged (14 000 g, 10 min, 4°C) to separate unbro-
ken cells. Cytoplasmic and membrane protein fractions were
separated by ultracentrifugation of the cell-free extract
(100 000 g, 1 h, 4°C). Inner membrane was selectively solu-
bilized by re-suspending the pellet in 2% Sodum Lauryl Sar-
kosyl in 10 mM Tris-Cl (pH 7.5) and centrifugation (10 000 g,
1 h, 4°C). The pellet containing the OM was solubilized using
1% zwittergen 4-14 (non-ionic detergent) in Buffer A (50 mM
NaPO4, 300 mM NaCl, 10 mM imidazole, pH 8.0) and rocked
at room temperature for 1 h. The suspension was centrifuged
(100 000 g, 1 h, 4°C) and the supernatant containing the
soluble OM was collected. Zwittergen percentage was
brought down to 0.1% by diluting the protein with Buffer A.
The highly enriched ~30 kDa OmpA protein (identified by
MALDI-TOF/MS) served as a marker to confirm successful
enrichment OM protein fraction using this procedure. The OM
protein suspension was mixed with slurry of 50% Ni-NTA
(Qiagen) and rocked at 4°C for 1 h to facilitate binding of the
protein to the Ni-NTA resin. The Ni-NTA and protein slurry
was washed with 10 column volumes of Buffer B (50 mM Na
phosphate, 300 mM NaCl and 30 mM imidazole, pH 8.0) and
Table 4. Plasmids and strains used in this study.
Plasmid Features and application Reference
pSAP2000B pta cloned into the BamHI–XhoI sites in pET21A to express C-terminus 6X-His-tagged Pta This study
pSAP2010 pta with S365A point mutation cloned into the BamHI–XhoI sites in pET21A to express
C-terminus 6X-His-tagged Pta
This study
pSAP2032 Alpha domain of Pta cloned into the BamHI–XhoI sites of pET21A to express C-terminus
6X-His-tagged Pta-a
This study
pSAP2012 pta gene segment corresponding to 844 amino acids towards the N-terminus cloned into the
BamHI–XhoI sites of pET21A
This study
pSAP2013 pta gene segment corresponding to 1016 amino acids towards the N-terminus cloned into
the BamHI–XhoI sites of pET21A
This study
pSAP2015 pta gene segment corresponding to 910 amino acids towards the N-terminus cloned into the
BamHI–XhoI sites of pET21A
This study
pSAP2018 pta gene segment corresponding to 1054 amino acids towards the N-terminus cloned into the
BamHI–XhoI sites of pET21A
This study
pSAP2034 pta cloned into the XhoI–HindIII sites of pBAD-Myc-His-A for overexpression in P. mirabilis HI4320 This study
pSAP2037 pACD4K (Sigma) carrying retargeted intron with pta homologous sequences. The plasmid is used for
insertional inactivation of Pta in P. mirabilis HI4320 and BA6163
This study
pSAP2038 Alpha domain of Pta with the S366A point mutation cloned into the BamHI–XhoI sites of pET21A to
express C-terminus 6X-His-tagged Pta-a(S366A)
This study
pSAP2039 pta with the S366A point mutation cloned into the XhoI–HindIII sites of pBAD-Myc-His-A
for overexpression in P. mirabilis HI4320
This study
pSAP2040 The alpha domain of Pta with the H147A point mutation cloned into the BamHI–HindIII sites of
pET21A to express a C-terminus 6X-His-tagged Pta-a(H147A)
This study
pSAP2041 pta carrying active-site point mutations S366A and H147A This study
pSAP2042 pET21A carrying Pta with C-terminal point mutations Y1063A, F1065A and Y1067A This study
HI4320 P. mirabilis catheter-associated wild-type strain. Tetracycline resistant Clinical isolate
BA6163 P. mirabilis urinary tract isolate. Tetracycline resistant Clinical isolate
ALM2000 Insertional inactivation of Pta using pSAP2037 in HI4320 This study
ALM2001 HI4320 expressing empty pBAD-Myc-His-A vector as control This study
ALM2002 HI4320 expressing pSAP2034 This study
ALM2003 ALM2000 expressing empty pBAD-Myc-His-A control This study
ALM2004 ALM2000 expressing pSAP2034 This study
ALM2005 HI4320 expressing pSAP2039 This study
ALM2006 ALM2000 expressing pSAP2039 This study
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finally eluted with Buffer C (50 mM Na phosphate, 300 mM
NaCl and 250 mM imidazole, pH 8.0 containing 0.05%
zwittergen). Protein purity was determined by running the
fractions on a 10% SDS-PAGE followed by Commassie
staining. Pure aliquots were dialysed against 1 l of Buffer A
with 0.015% zwittergen at 4°C for 2 days. Protein was elec-
trophoresed on 10% SDS-PAGE and bands were cut out of
the gel and identified by MALDI-TOF/MS at the University of
Michigan Protein Consortium. Protein was concentrated and
quantified using BCA assay (Pierce). To identify both potential
signal sequence and the secondary cleavage site in Pta, the
purified protein fraction was electrophoresed on a 10% SDS-
PAGE, transblotted onto a PVDF membrane and the amino
black stained bands were excised for N-terminus sequencing
at Emory School of Medicine Research Core Laboratories.
C-terminal truncations of Pta and their
cellular localization
The amino acid sequence of Pta was subjected to secondary
structure prediction by PredictProtein and the regions of high
hydrophobicity with potential for forming antiparallel beta
sheets and the connecting hydrophilic loops were determined
as described earlier. Nine different regions with the potential
of forming antiparallel beta sheets and eight connecting
hydrophilic coils were identified. Primers were designed to
obtain C-terminus truncations at four of the eight connecting
regions (at residues 844, 910, 1016 and 1054) that were
approximately at 30-amino-acid intervals (Table 4). These
truncated genes were amplified by PCR using the Pta-For
and the corresponding 3′ primer (carrying the restriction site
for XhoI) and the individual PCR products were cloned
into pET21A vector. To generate Pta-1072*, nucleotide
sequences corresponding to amino acid residues Tyr1063,
Phe1065 and Tyr1067 were altered to the respective alanines
using Strategene’s Quick Change® Site Directed Mutagen-
esis kit using plasmid pSAP200B as template. The resulting
plasmid was designated pSAP2042. All clones were con-
firmed by DNA sequencing at the University of Michigan DNA
Sequencing Core facility. Vectors carrying various truncations
were individually transformed into E. coli BL21plysS and
were overexpressed as described previously. Cytoplasmic
and OM fractions for each truncated protein were enriched
using a similar procedure as described above. Protein
(10 mg) from each mutant was run on a 10% SDS-PAGE.
Truncated Pta was detected by immunoblotting using 1:750
dilution of Anti-Pta antibody and 1:30 000 of Goat Anti-Rabbit
IgG-Horse Radish Peroxidase (HRP) conjugate.
Purification of C-terminal 6X-His-tagged Pta-a and its
active-site variants
DNA corresponding to the passenger domain of the AT
(amino acids 1–730) was amplified using primers PTAFor and
Pta730Rev and cloned into expression vector pET21A.
Active-site variants (S366A and H147A) were obtained using
Strategen’s Quick Change® Site Directed Mutagenesis Kit in
a similar procedure as described above. The proteins were
individually expressed in E. coli BL21plysS and were affinity
purified from the cytoplasmic protein mixture of E. coli
BL21plysS using Ni-NTA agarose resin. The same buffers
used for Pta-6X-His were used here but without the
detergent. The purified protein was electrophoresed on a
12% SDS-PAGE and the bands were excised to confirm the
protein identity by MALDI-TOF/MS.
Protease activity
Proteolytic activity was measured using the above mentioned
chromogenic substrates in 50 mM NaPO4 buffer, pH 8.5, con-
taining 20 mM CaCl2 and 0.005% Triton X-100. Reactions
were performed in white-bottom 96-well plates containing
the appropriate amount of protease, a range of substrate
concentrations (10–150 mM), and reaction buffer to a final
volume of 250 ml. Protease activity was measured as an
increase in the OD412 due to cleavage of substrate at 37°C. A
unit of protease activity was defined as micromoles substrate
cleaved per milligram of protein per minute. Where noted, a
unit activity was defined as the amount of enzyme that
caused an increase in the absorbance by 0.1 per min.
For determination of pH optimum, pure protein was first
incubated in carbonate buffers (pKa 2.3 and 6.4) with differ-
ent pH ranging from 5.5 to 11 and its stability was assessed
by running on a 10% SDS-PAGE. The effect of pH on
the protease activity to N-Suc–Ala–Ala–Pro–Phe–pNa was
assayed with the above mentioned buffer in the pH range
between 5.5 and 11. Reactions were carried out as described
above with a standard substrate (100 mM) and enzyme
(50 nM) concentrations. Activity was determined by cleavage
of the substrate and was monitored at OD412.
To determine the effect of inhibitors, the enzyme (50 nM)
was allowed to complex with an inhibitor (10 mM) for 30 min
in the above mentioned buffer and the residual protease
activity was measured using 100 mM N-Suc–Ala–Ala–Pro–
Phe–pNa as described above.
Interaction of bacterial cells with epithelial monolayer
Interaction of Pta with epithelial cell monolayer was assessed
using whole cells of E. coli BL21plysS expressing Pta or its
active-site serine variant. Briefly, human kidney epithelial
cells (HEK293), human bladder epithelial cells (UMUC3),
mouse kidney epithelial (MMK.5) or Hamster kidney epithelial
(BHK21) were cultured as monolayers in 24-well tissue
culture-treated plate containing DMEM supplemented with
10% FBS, 10 mg ml-1 penicillin/streptomycin and 10 mg ml-1
glutamine. For microscopic examination, monolayers were
cultured on poly L-lysine-treated 12 mm coverslips in 24-well
plates. Prior to inoculation with bacterial cells, the medium
was changed to pre-warmed DMEM with 10% glutamine. To
examine the interaction of E. coli BL21plysS (5 ¥ 107 cells)
expressing either the vector alone, Pta or Pta(S365A) were
overlaid onto tissue culture cells. The plate was centrifuged at
500 g for 5 min and incubated at 37°C for 45 min. For the
quantitative cell adhesion assay wells were washed (5¥) with
PBS, pre-warmed to 37°C, to remove any unbound bacterial
cells. The wells were then treated with 0.25% trypsin-EDTA to
remove the bound monolayer and various dilutions were
plated on LB agar plates. For microscopic examination, the
monolayer was fixed with 4% paraformaldehyde for 10 min
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after initial washes. Fixative was aspirated and the wells
were washed (3¥) with PBS and stained with Giemsa (1:30 in
10% methanol) for 15 min followed by destaining with 10%
methanol. Coverslips were dried and mounted onto the glass
slides. Similar procedure was followed to study the interac-
tion of various strains of P. mirabilis with different epithelial
cell lines. Slides were examined using Olympus BX60 immu-
nofluorescence microscope and images were taken using
Olympus DP70 camera. For quantitative estimation, epithelial
cells were grown in poly L-lysine-treated 96-well plates and
infected with E. coli cells expressing various versions of Pta.
After incubation for 1 h at 37°C, the supernatant was col-
lected and LDH release was estimated as described below.
Interaction of pure protease with the host cells
To determine the interaction of purified Pta, Pta-a or their
active-site variants with the host, bladder or kidney epithelia
were cultured in tissue culture-treated multichamber glass
slides containing DMEM supplemented with 10% FBS +
5 mg ml-1 streptomycin/penicillin and 10 mg ml-1 glutamine.
Medium was changed to pre-warmed DMEM + 10%
glutamine and the cells were treated with known amounts of
Pta or the buffer control and incubated at 37°C. At various
time intervals, chambers were washed (5¥) with PBS, fixed
and stained with Giemsa as described above. For immunof-
luorescent detection of cell morphology, cells were fixed,
permeabilized by treating with 0.1% Triton-X in PBS for
10 min. The slides were then washed (3¥) with pre-warmed
PBS and blocked with 2% BSA for 1 h at 30°C followed by
staining with FITC-phalloidin and DAPI (both in PBS with 1%
BSA) under dark for 30 min at room temperature (Product
No. F432 and D3571, Invitrogen, CA, USA). Slides were
washed (5¥) with PBS, air-dried and mounted using Prolong
Gold Anti-Fade® (Invitrogen; Product No. P36930) covered
and incubated at 4°C overnight. Slides were examined using
Olympus BX60 immunofluorescence microscope and the
images were recorded with an Olympus DP70 camera.
Quantitative estimation of cytotoxicity by lactate
dehydrogenase release
Extent of host cell lysis was estimated indirectly by measuring
the release of intracellular lactate dehydrogenase from the
nucleated cells using Cytox® Membrane Permeability Assay
from Promega, Madison, USA (Product No. G7890) as
described elsewhere (Kehl-Fie and St Geme, 2007). Briefly,
epithelial cells were cultured in poly L-lysine-treated 96-well
plates in the above described medium. Medium was changed
to DMEM + 10% glutamine prior to infection with a known
concentration of either purified wild-type Pta, Pta-a or their
active-site variants and incubated at 37°C. Plates were
removed at various time points and the substrate reagent
was added to all wells and incubated by brief shaking at room
temperature for 20 min. Stop solution was added to the wells
and the fluorescence was measured at 560–590 nm on Syn-
ergyTM HT Multi-Detection Microplate reader from Bio Tek.
Treatment with PBS containing 0.015% Zwitterngen and with
2.5% Triton X-100 was used as controls. Cytotoxicity of the
protein was expressed as a per cent of maximum cell lysis
obtained by Triton X-100 treatment after normalizing the
values obtained from treatment with buffer only control.
Construction of a pta mutant and complementation
in trans
Targetron® (Sigma) was used for insertional inactivation of
pta in HI4320 (Table 4). The procedure was modified as
described by Pearson and Mobley (2007). The mutant
ptaWaphA3 was confirmed PCR and sequencing and also
using polyclonal Anti-Pta antibody.
For complementation, wild-type copy of pta was cloned into
the overexpression vector pBAD Myc-His. The active-site
Ser366Ala variant was obtained by a similar procedure as
described earlier but by using pBAD-pta as the template. The
vector carrying either the wild type or the site-directed mutant
was transformed into ptaWaphA3 to complement in trans.
Percentage of arabinose was titrated to control the level of
Pta expression in the mutant to that of the expression in the
wild-type strain. We found that induction with 2% arabinose
for 2 h produced enough protein to match with the expression
levels to that of the wild-type strain. The percentage of ara-
binose was increased to 5% to overexpress the pta either in
the wild type or the isogenic pta mutant, and the amount of
Pta in the latter was found to be at least threefold higher than
in the 2% induced cells. Complementation was confirmed by
immunostaining the OM fractions with polyclonal anti-Pta
antibody (1:1000) followed by staining with Goat Anti-Rabbit
IgG-HRP conjugate (1:50 000). Protein bands were visual-
ized by chemiluminescent detection using ECL Western Blot-
ting Detection Substrate (Product No. RPN2106) from Pierce,
Rockland, IL, USA.
Effect of growth conditions in the expression of pta
in P. mirabilis HI4320
Proteus mirabilis wild-type strain HI4320 was grown under
different conditions of temperature (25°C, 37°C and 42°C),
pH (5.0, 7.0 and 9.0), salt concentration (0.5 M NaCl), iron
stress (0.5 mM FeSO4 or 15 mM desferral), metal ion supple-
mentation (0–5 mM MgCl2 or 20 mM CaCl2; independently at
pH 7.0 and pH 9.0). The OM fraction was extracted indepen-
dently from each of the above conditions and the presence of
Pta was determined by immunostaining with Anti-Pta poly-
clonal antisera. Intensity of Pta-specific bands was quantified
using ImageJ software from http://www.nih.gov and fold
increases or decreases in protein expression in each case
was compared with that expressed in exponential-phase bac-
teria cultured at 37°C in LB pH 7.0. Alternatively, quantitative
RT-PCR was performed to measure expression of pta, and
P. mirabilis strains were cultured to mid-exponential phase
(OD600 = 0.8) under each of the above said conditions.
RNAprotect (2 ml) (Qiagen) was added to 1 ml of culture, and
RNA was isolated using the RNeasy kit (Qiagen) according to
the manufacturer’s instructions. DNA was digested using
TURBO DNA-free DNase (Ambion). RNA was used as the
template for cDNA synthesis using the Superscript First-
Strand Synthesis System (Invitrogen) according to the manu-
facturer’s protocol. rpoA (DNA-dependent RNA polymerase
Alpha) was used as the normalizer and RNA isolated from
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P. mirabilis HI4320 cultured at 37°C in LB pH 7.0 was used
as the calibrator. Fold change in expression of pta was
expressed relative to the calibrator.
Interaction of P. mirabilis with eukaryotic hosts
Confluent epithelial cell monolayers were obtained as
described earlier. Wild type, mutant or either strains overex-
pressing pta on plasmid were cultured in LB broth supple-
mented with 4% glycerol and 20 mM CaCl2. The pH was
adjusted to 8.5 using potassium phosphate. Where appropri-
ate, bacteria were cultured until OD600 equalled 0.6 and
induced with 5% arabinose for 3 h. Cells were washed with
PBS (3¥) and re-suspended in phosphate buffer (pH 8.5) and
overlaid onto confluent bladder or kidney epithelial cells to
assess Pta-mediated interaction. LDH release from the
eukaryotic host was estimated as described above.
Autoagglutination assay
To quantitatively estimate autoagglutination by P. mirabilis,
various strains were cultured, induced and processed as
described above. Cells were finally re-suspended in 10 ml of
phosphate buffer (pH 8.5) to a cell density of 450–480 Klett
units. Cell density (Klett units) was measured at different time
points using Klett-Summerson Photoelectric Colorimeter
(Klett MFG, NY, USA). The drop in Klett unit reading from the
initial cell density of 450–480 units together with the formation
of clumping in the bottom of the tube reflects the degree of
autoagglutination.
Mouse model of ascending UTI
The CBA/J mouse model of ascending UTI has been
described previously (Li et al., 1999). Briefly, 6-week-old
female CBA/J mice were inoculated transurethrally with a
50 ml suspension of 5 ¥ 107 cfu of P. mirabilis HI4320 wild
type and the ptaWaphA3 mutant (1:1). At 7 days post infec-
tion, urine, and the tissue homogenates of bladders, kidneys,
and spleen of the mice were examined for the presence of
P. mirabilis by plating on LB and LB + Kan (25 mg ml-1) using
a spiral plater (Autoplate 4000, Spiral Biotech). Colony
counts were enumerated using a QCount (Spiral Biotech)
and expressed as cfu per gram of tissue or cfu per millilitre of
urine. Statistical significance of the data was determined
using the Wilcoxon matched pairs test.
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Amy N. Simms, Stēphane L. Benoit and Suleyman Felek for
critical reading of this manuscript and Smitha Thatha for proof
reading and formatting of figures. The project was funded by
public health service Grant AI-059722 from the National Insti-
tutes of Health to H.L.T.M. MALDI-TOF MS/MS analysis was
provided by the Michigan Proteome Consortium (http://www.
proteomeconsortium.org) which is supported in part by funds
from the Michigan Life Sciences Corridor.
References
Backert, S., and Meyer, T.F. (2006) Type IV secretion
systems and their effectors in bacterial pathogenesis. Curr
Opin Microbiol 9: 207–217.
Cainelli Gebara, V.C., Risoleo, L., Lopes, A.P., Ferreira, V.R.,
Quintilio, W., Lepine, F., et al. (2007) Adjuvant and immu-
nogenic activities of the 73 kDa N-terminal alpha-domain of
BrkA autotransporter and Cpn60/60 kDa chaperonin of
Bordetella pertussis. Vaccine 25: 621–629.
Chippendale, G.R., Warren, J.W., Trifillis, A.L., and Mobley,
H.L. (1994) Internalization of Proteus mirabilis by human
renal epithelial cells. Infect Immun 62: 3115–3121.
Cianciotto, N.P. (2005) Type II secretion: a protein secretion
system for all seasons. Trends Microbiol 13: 581–588.
Coker, C., Poore, C.A., Li, X., and Mobley, H.L. (2000)
Pathogenesis of Proteus mirabilis urinary tract infection.
Microbes Infect 2: 1497–1505.
Cotter, S.E., Surana, N.K., and St Geme, J.W., 3rd (2005)
Trimeric autotransporters: a distinct subfamily of autotrans-
porter proteins. Trends Microbiol 13: 199–205.
Cotter, S.E., Surana, N.K., Grass, S., and St Geme, J.W., 3rd
(2006) Trimeric autotransporters require trimerization of
the passenger domain for stability and adhesive activity.
J Bacteriol 188: 5400–5407.
Girard, V., and Mourez, M. (2006) Adhesion mediated by
autotransporters of Gram-negative bacteria: structural and
functional features. Res Microbiol 157: 407–416.
Guyer, D.M., Radulovic, S., Jones, F.E., and Mobley, H.L.
(2002) Sat, the secreted autotransporter toxin of uropatho-
genic Escherichia coli, is a vacuolating cytotoxin for
bladder and kidney epithelial cells. Infect Immun 70: 4539–
4546.
Harris, P.R., Cover, T.L., Crowe, D.R., Orenstein, J.M.,
Graham, M.F., Blaser, M.J., and Smith, P.D. (1996) Heli-
cobacter pylori cytotoxin induces vacuolation of primary
human mucosal epithelial cells. Infect Immun 64: 4867–
4871.
Henderson, I.R., and Nataro, J.P. (2001) Virulence functions
of autotransporter proteins. Infect Immun 69: 1231–
1243.
Henderson, I.R., Navarro-Garcia, F., and Nataro, J.P. (1998)
The great escape: structure and function of the autotrans-
porter proteins. Trends Microbiol 6: 370–378.
Henderson, I.R., Czeczulin, J., Eslava, C., Noriega, F., and
Nataro, J.P. (1999) Characterization of pic, a secreted
protease of Shigella flexneri and enteroaggregative
Escherichia coli. Infect Immun 67: 5587–5596.
Henderson, I.R., Navarro-Garcia, F., Desvaux, M., Fernan-
dez, R.C., and Ala’Aldeen, D. (2004) Type V protein secre-
tion pathway: the autotransporter story. Microbiol Mol Biol
Rev 68: 692–744.
Hutton, J.C. (1990) Subtilisin-like proteinases involved in
the activation of proproteins of the eukaryotic secretory
pathway. Curr Opin Cell Biol 2: 1131–1142.
Johnson, D.E., Russell, R.G., Lockatell, C.V., Zulty, J.C.,
Warren, J.W., and Mobley, H.L. (1993) Contribution of
Proteus mirabilis urease to persistence, urolithiasis, and
acute pyelonephritis in a mouse model of ascending
urinary tract infection. Infect Immun 61: 2748–2754.
Kehl-Fie, T.E., and St Geme, J.W., 3rd (2007) Identification
1016 P. Alamuri and H. L. T. Mobley 
© 2008 The Authors
Journal compilation © 2008 Blackwell Publishing Ltd, Molecular Microbiology, 68, 997–1017
and characterization of an RTX toxin in the emerging
pathogen Kingella kingae. J Bacteriol 189: 430–436.
Klemm, P., Vejborg, R.M., and Sherlock, O. (2006) Self-
associating autotransporters, SAATs: functional and struc-
tural similarities. Int J Med Microbiol 296: 187–195.
Kluskens, L.D., Voorhorst, W.G., Siezen, R.J., Schwerdt-
feger, R.M., Antranikian, G., van der Oost, J., and de Vos,
W.M. (2002) Molecular characterization of fervidolysin,
a subtilisin-like serine protease from the thermophilic
bacterium Fervidobacterium pennivorans. Extremophiles
6: 185–194.
Li, X., and Mobley, H.L. (2002) Vaccines for Proteus mirabilis
in urinary tract infection. Int J Antimicrob Agents 19: 461–
465.
Li, X., Johnson, D.E., and Mobley, H.L. (1999) Requirement
of MrpH for mannose-resistant Proteus-like fimbria-
mediated hemagglutination by Proteus mirabilis. Infect
Immun 67: 2822–2833.
Liu, D.F., Mason, K.W., Mastri, M., Pazirandeh, M., Cutter,
D., Fink, D.L., et al. (2004) The C-terminal fragment of the
internal 110-kilodalton passenger domain of the Hap
protein of nontypeable Haemophilus influenzae is a poten-
tial vaccine candidate. Infect Immun 72: 6961–6968.
Mobley, H.L. (1996a) Urinary Tract Infections: Molecular
Pathogenesis and Clinical Management. Washington, DC:
American Society for Microbiology Press, pp. 245–270.
Mobley, H.L. (1996b) Virulence of Proteus mirabilis. In
Urinary Tract Infections: Molecular Pathogenesis and Clini-
cal Management. Mobley, H.L., and Warren, J.W. (eds).
Washington, DC: American Society for Microbiology Press,
pp. 245–269.
Mobley, H.L., and Warren, J.W. (1987) Urease-positive bac-
teriuria and obstruction of long-term urinary catheters.
J Clin Microbiol 25: 2216–2217.
Mobley, H.L., Chippendale, G.R., Swihart, K.G., and Welch,
R.A. (1991) Cytotoxicity of the HpmA hemolysin and
urease of Proteus mirabilis and Proteus vulgaris against
cultured human renal proximal tubular epithelial cells.
Infect Immun 59: 2036–2042.
Mota, L.J., and Cornelis, G.R. (2005) The bacterial injection
kit: type III secretion systems. Ann Med 37: 234–249.
Navarro-Garcia, F., Sears, C., Eslava, C., Cravioto, A., and
Nataro, J.P. (1999) Cytoskeletal effects induced by pet, the
serine protease enterotoxin of enteroaggregative Escheri-
chia coli. Infect Immun 67: 2184–2192.
Navarro-Garcia, F., Canizalez-Roman, A., Sui, B.Q., Nataro,
J.P., and Azamar, Y. (2004) The serine protease motif of
EspC from enteropathogenic Escherichia coli produces
epithelial damage by a mechanism different from that of
Pet toxin from enteroaggregative E. coli. Infect Immun 72:
3609–3621.
Navarro-Garcia, F., Canizalez-Roman, A., Burlingame, K.E.,
Teter, K., and Vidal, J.E. (2007) Pet, a non-AB toxin, is
transported and translocated into epithelial cells by a ret-
rograde trafficking pathway. Infect Immun 75: 2101–2109.
Paton, A.W., Srimanote, P., Talbot, U.M., Wang, H., and
Paton, J.C. (2004) A new family of potent AB(5) cytotoxins
produced by Shiga toxigenic Escherichia coli. J Exp Med
200: 35–46.
Paton, A.W., Beddoe, T., Thorpe, C.M., Whisstock, J.C.,
Wilce, M.C., Rossjohn, J., et al. (2006) AB5 subtilase cyto-
toxin inactivates the endoplasmic reticulum chaperone BiP.
Nature 443: 548–552.
Pearson, M.M., and Mobley, H.L. (2007) The type III secre-
tion system of Proteus mirabilis HI4320 does not contribute
to virulence in the mouse model of ascending urinary tract
infection. J Med Microbiol 56: 1277–1283.
Pearson, M.M., Sebaihia, M., Churcher, C., Quail, M.A.,
Seshasayee, A.S., Abdellah, Z., et al. (2008) The complete
genome sequence of uropathogenic Proteus mirabilis, a
master of both adherence and motility. J Bacteriol (in
press).
Rocha, S.P., Elias, W.P., Cianciarullo, A.M., Menezes, M.A.,
Nara, J.M., Piazza, R.M., et al. (2007) Aggregative adher-
ence of uropathogenic Proteus mirabilis to cultured epithe-
lial cells. FEMS Immunol Med Microbiol 51: 319–326.
Salama, N.R., Otto, G., Tompkins, L., and Falkow, S. (2001)
Vacuolating cytotoxin of Helicobacter pylori plays a role
during colonization in a mouse model of infection. Infect
Immun 69: 730–736.
Seizen, R.J. (1996) Subtilases: subtilisin-like serine
proteases. Adv Exp Med Biol 379: 75–93.
Stathopoulos, C., Hendrixson, D.R., Thanassi, D.G.,
Hultgren, S.J., St Geme, J.W., 3rd, and Curtiss, R., 3rd
(2000) Secretion of virulence determinants by the general
secretory pathway in gram-negative pathogens: an evolv-
ing story. Microbes Infect 2: 1061–1072.
Steiner, D.F. (1998) The proprotein convertases. Curr Opin
Chem Biol 2: 31–39.
Stickler, D., Ganderton, L., King, J., Nettleton, J., and
Winters, C. (1993) Proteus mirabilis biofilms and the
encrustation of urethral catheters. Urol Res 21: 407–411.
Swihart, K.G. and Welch, R.A. (1990) Cytotoxic activity of the
Proteus hemolysin HpmA. Infect Immun 58: 1861–1869.
Tukel, C., Akcelik, M., de Jong, M.F., Simseko, O., Tsolis,
R.M., and Baumler, A.J. (2007) MarT activates expression
of the MisL autotransporter protein in Salmonela enterica
serotype Typhimurium. J Bact 189: 3922–3926.
Warren, J.W., Tenney, J.H., Hoopes, J.M., Muncie, H.L., and
Anthony, W.C. (1982) A prospective microbiologic study of
bacteriuria in patients with chronic indwelling urethral
catheters. J Infect Dis 146: 719–723.
Warren, J.W., Damron, D., Tenney, J.H., Hoopes, J.M.,
Deforge B., and Muncie, H.L., Jr (1987) Fever, bacteremia,
and death as complications of bacteriuria, in women
with long-term urethral catheters. J Infect Dis 155: 1151–
1158.
Wells, T., Tree, J.J., Ulett, G.L., and Schembi, M.A. (2007)
Autotransporter proteins: novel targets at the bacterial cell
surface. FEMS Microbiol Lett 274: 163–172.
Bi-functional autotransporter of Proteus mirabilis 1017
© 2008 The Authors
Journal compilation © 2008 Blackwell Publishing Ltd, Molecular Microbiology, 68, 997–1017
